Table 1. Composition of participant gender and medication regimen.

OAC, oral anticoagulation; DAPT, dual antiplatelet therapy

Gender of patients	Frequency n (%)
Males	101 (67.33)
Females	49 (32.60)
Drug regimen at implant		Male gender frequency (%)	Female gender frequency n (%)	P-value
OAC	74 (49.33)	54 (53.46)	20 (40.82)	<0.01
DAPT	54 (36.00)	31 (30.69)	23 (46.94)	0.22
None	12 (8.00)	9 (8.91)	3 (6.12)	0.08
Unsuccessful implant	10 (6.66)	7 (6.93)	3 (6.12)	0.19